Literature DB >> 16989196

Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid.

Elena Maydan1, Pavan K Nootheti, Mitchel P Goldman.   

Abstract

Since its FDA approval in 1999, photodynamic therapy (PDT) with topical 5-aminolevulinic acid has become an increasingly popular modality for the treatment of actinic keratosis (AKs). It is hoped that in addition to improving clinical signs and symptoms of AKs, PDT might prevent the development of skin cancer. We present a case of a patient developing a keratoacanthoma immediately following PDT for AKs.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16989196

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


  4 in total

1.  CD1A-positive cells and HSP60 (HSPD1) levels in keratoacanthoma and squamous cell carcinoma.

Authors:  Daniela Cabibi; Everly Conway de Macario; Sabrina Ingrao; Rossana Porcasi; Francesco Zucco; Alberto J L Macario; Francesco Cappello; Francesca Rappa
Journal:  Cell Stress Chaperones       Date:  2015-10-06       Impact factor: 3.667

Review 2.  Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.

Authors:  Silvia Rocío Lucena; Nerea Salazar; Tamara Gracia-Cazaña; Alicia Zamarrón; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

3.  Use of photodynamic therapy and acitretin in generalized eruptive keratoacanthoma of Grzybowski.

Authors:  Stephanie Mlacker; Urvashi Kaw; Edward V Maytin
Journal:  JAAD Case Rep       Date:  2017-09-08

Review 4.  Early and Late Onset Side Effects of Photodynamic Therapy.

Authors:  Francesco Borgia; Roberta Giuffrida; Emanuela Caradonna; Mario Vaccaro; Fabrizio Guarneri; Serafinella P Cannavò
Journal:  Biomedicines       Date:  2018-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.